top of page
Research Interests and Clinical Trials

 

Link to Pubmed 

​

  1. Primary / Co-Investigator (Investigator Initiated – ongoing)

    1. ATTRaCT - Asian neTwork for Translational Research and Cardiovascular Trials (NCT 02791009)

    2. SAVIOUR - Biomarkers and Management of Cardiovascular Disease

      1. SAVIOUR-AS Biomarker Evaluation in Aortic Stenosis

      2. SAVIOUR-MR Biomarker Evaluation in Mitral Regurgitation

      3. SAVIOUR-MVP Proteomics Discovery of Biomarkers for Mitral Valve Prolapse and Biobanking DNA for Genetic Studies in Mitral Valve Prolapse

    3. ASIAN-HF registry – (NCT01633398)

    4. SingCLOUD - Long-term clinical outcomes, cost-of-care, clinical characteristics, re-admission rates, outpatient care and mortality in patients with coronary artery disease or congestive heart failure in Singapore (SINGCLOUD for Singapore Cardiac Longitudinal OUtcomes Database Study) (DSRB - 2013/00462)

  2. Primary / Co-Investigator (Industry Initiated - ongoing)

    1. VICTORIA - A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001). (NCT02861534)

  3. Primary Investigator (Investigator Initiated – completed)

    1. CLOPRA: CLOpidogrel-PRAsugrel switch study in Southeast-Asian Acute Coronary Syndrome requiring PCI: A Cost Effectiveness Study

    2. CONTRAST (COmbined acetylcysteine and bicarbonate in Cardiac Catheterisation To Reduce Adverse Side effect of contrasT) – (NCT 00497328)

    3. Development and evaluation of the nurse-led telephone follow-up program in post-acute coronary syndrome patients.(DSRB - 2013/00666)

    4. SAFE: Singapore Armed Forces Echocardiogram and ECG study

    5. PEOPLES – Prospective Evaluation of Outcome for Patients with Heart Failure with Preserved Left Ventricular Ejection Fraction.

    6. SHOP - Singapore Heart Failure Outcomes and Phenotypes

    7. Genotype-Guided Warfarin Dosing (WarfGen) in Local Patients Initiating Oral Anticoagulation: a Quality Assurance Study. (DSRB - 2013/00160)

    8. P2Y12 inhibitors in Acute Coronary Syndrome (PACS): Ticagrelor in ST-Elevation Myocardial Infarction. (DSRB - 2012/01137)

    9. ASThein-DI: Asian Study of Thienopyridine-Drug Interactions

    10. Assessment of myocardial perfusion imaging with cardiac CT. (DSRB 2013/00004)

  4. Primary / Co-Investigator (Industry Initiated - completed)

    1. ODYSSEY Outcomes - Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab SAR236553 (REGN727) - Site 702003. (NCT01663402)

    2. FOURIER - Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk. (NCT01764633)

    3. COMPARE-ACUTE- Comparison Between FFR Guided Revascularization Versus Conventional Strategy in Acute STEMI Patients With MVD. (NCT01399736)

    4. CL2-38844-010 -  Evaluation of the pharmacodynamics, pharmacokinetics and safety of repeated escalating oral doses of S 38844 versus placebo in patients with chronic heart failure and left ventricular systolic dysfunction - A phase II, randomised, double-blind, parallel-group, placebo controlled, international multicentre study (EudraCT: 2013-003000-39)

    5. SOCRATES-REDUCED - Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure With Reduced Ejection Fraction Suffering From Worsening Chronic Heart Failure (NCT01951625)

    6. SOCRATES-PRESERVED -  Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure and Preserved Ejection Fraction Suffering From Worsening Chronic Heart Failure (NCT01951638)

    7. PARADIGM-HF (LCZ696B2314) – A multi-center, randomised, double-blind, parallel group, active-controlled study to evaluate the efficacy and safety of LCZ696 therapy compared to enalapril on morbidity and mortality in patients with chronic heart failure (NYHA Class II – IV) with reduced systolic function – (NCT01035255)

    8. X-VERT - Explore the Efficacy and Safety of Once-daily Oral Rivaroxaban for the Prevention of Cardiovascular Events in Subjects With Nonvalvular Atrial Fibrillation Scheduled for Cardioversion – (NCT01674647)

    9. AVERROES (Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or are Unsuitable for Vitamin K Antagonist Treatment:  A Randomized Double Blind Trial) – (NCT 00496769)

    10. ROCKET AF (A Prospective, Randomized, Double-Blind, Double-Dummy, Parallel-Group, Multicenter, Event-Driven Non-Inferiority Study Comparing the Efficacy and Safety of Once-Daily Oral Rivaroxaban (Bay 59-7939) with Adjusted-Dose Oral Warfarin for the Prevention of Stroke and Non-Central Nervous Systemic Embolism in Subjects with Non-Valvular Atrial Fibrillation) – (NCT00403767)

    11. CL3- 05985-018 - Perindopril arginine/Amlodipine versus Valsartan/Amlodipine antihypertensive strategies: Efficacy and safety in mild to moderate hypertensive patients. A randomised, double-blind 6-month study followed by 8-month open label long-term follow-up with Perindopril arginine/Amlodipine.

    12. AFFILIATE  (A1481324) - A multinational, multicenter study to assess the effects of oral sildenafil on mortality in Adults with Pulmonary Arterial Hypertension (PAH). (EudraCT: 2013-004362-34, NCT02060487)

    13. PARAGON-HF - Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction. (NCT01920711)

  5. Co-investigator in Phase III clinical drug studies (completed)

    1. Val-Heft (Valsartan in Heart Failure) 1998

    2. CHARM (Candesartan Cilexetil in Heart Failure: Assessment of Reduction in Mortality and Morbidity) - (NCT00634400, NCT00634309, NCT00634712) 1998

    3. IONA (Impact of Nicorandil in Angina) 1998

    4. OVERTURE (Omapatrilat versus Enalapril Randomised Trial of Utility in Reducing Events) 1998

    5. RECOVER (Research into ENBREL: Cytokine Antagonism in Ventricular Dysfunction) 1998

    6. CRESCENDO (Comprehensive Rimonabant Evaluation Study of Cardiovascular ENDpoints and Outcomes) 2005

    7. Trilogy ACS (H7T-MC-TABY) - A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome (ACS) Subjects with Unstable Angina/Non-ST-Elevation Myocardial Infarction (UA/NSTEMI) Who are Medically Managed – (NCT00699998)

    8. APPRAISE-2 (Apixaban for Prevention of Acute Ischemic Events) - A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects with a Recent Acute Coronary Syndrome – (NCT00831441)

    9. ASTRONAUT (CSPP100A2368) - A multicenter, randomized, double-blind, parallel group, placebo-controlled study to evaluate the 6 months efficacy and safety of aliskiren therapy on top of standard therapy, on morbidity and mortality when initiated early after hospitalization for acute decompensated heart failure - NCT00894387

    10. PARAMOUNT (LCZ696B2214) -  A twelve-week, randomized, double-blind, multi-center, parallel group, active controlled study to evaluate the efficacy, safety and tolerability of LCZ696 compared to valsartan in patients with chronic heart failure and preserved left-ventricular ejection fraction

​

Mount Elizabeth Novena Specialist Centre

38 Irrawaddy Road, #07-41

Singapore 329563

Tel: +65 6254 6678

Fax: +65 6254 6676

​

​

Email: info@cardiacsolutions.sg

​

Clinic Mobile: +65 9862 9450 (WhatsApp / WeChat preferable)

CopyLeft Notice of www. cardiacsolutions.sg

All original material that appears on this website is copyleft, meaning that it may be reproduced by anyone for any purpose, as long as such activity is not profit-driven/commercial. Exceptions are when another work has been quoted such as (and not limited to) Public Domain articles. Altered and critiqued versions may be redistributed so long as it is clearly noted that such alterations were made and that the individual or organization claims responsibility for editing the work. If you wish to reproduce a work, I kindly ask that a link to www.cardiacsolutions.sg is attached. It would be greatly appreciated if only this URL is republished, and not an e-mail address.

bottom of page